Chemometrically Assisted Development and Validation of LC for Simultaneous Determination of Carbamazepine and Its Impurities Iminostilbene and Iminodibenzyl in Solid Dosage Form

被引:0
作者
Predrag Džodić
Ljiljana Živanović
Ana Protić
Mira Zečević
Biljana Jocić
机构
[1] University of Niš,Department of Pharmacy, Faculty of Medicine
[2] University of Belgrade,Institute of Drug Analysis, Faculty of Pharmacy
来源
Chromatographia | 2009年 / 70卷
关键词
Column liquid chromatography; Fractional factorial design; Central composite design; Carbamazepine; Iminostilbene and iminodibenzyl;
D O I
暂无
中图分类号
学科分类号
摘要
A chemometrical approach was applied to develop a reversed-phase liquid chromatographic method for simultaneous determination of carbamazepine and its impurities iminostilbene and iminodibenzyl in solid dosage form. According to contemporary literature, no method was developed for simultaneous determination of carbamazepine and these impurities by chemometrical approach. The fractional factorial design was used for selection of variables significantly influencing the chromatographic separation of the investigated substances. The investigated variables were: temperature of the column, the percentage of organic modifier, the acetate buffer concentration and pH of water phase. The first three variables were proved to be significant and were optimized by face centered, central composite design. Investigation was performed using C18 XBridge Shield analytical column (50 mm × 4.6 mm i.d., particle size 3.5 µm). The optimal conditions for the separation were established with the mobile phase composition of methanol–10 mM acetate buffer (pH adjusted to 2.21 with glacial acetic acid) (50:50, v/v) at a flow rate of 1.5 mL min−1, 25 °C column temperature and detection at 260 nm. Total analysis time was shortened to about 8 min. Finally, the method was successfully validated and subsequently applied to the analysis of commercially available carbamazepine tablets.
引用
收藏
页码:1343 / 1351
页数:8
相关论文
共 113 条
  • [1] Levert H(2002)undefined Biomed Chromatogr 16 19-24
  • [2] Odou P(2002)undefined Clin Chem 48 1696-1702
  • [3] Robert H(1995)undefined Catal Lett 31 197-207
  • [4] Martinavarro-Domínguez A(2006)undefined Fed Regist 68 64628-64629
  • [5] Capella-Peiró ME(2006)undefined Fed Regist 68 6924-6925
  • [6] Gil-Agustí M(2002)undefined J Chromatogr B 769 1-7
  • [7] Marcos-Tomás JV(2006)undefined J Pharm Biomed Anal 41 1386-1390
  • [8] Esteve-Romero J(2008)undefined J Sep Sci 31 1-8
  • [9] Knell A(2006)undefined Anal Bioanal Chem 386 1931-1936
  • [10] Monti D(2001)undefined J Chromatogr B 762 109-116